Skip to main content
Caplight Logo









Mabgeek Biotechnology

Mabgeek Biotechnology

Private
BeijingHealthcare & Life Scienceshttps://mabgeek.com/

Last Round

IPO

Jul 14, 2025

Est. Valuation

$368.11M

Total Funding Raised

$53.7M

Momentum

Top 50%

of companies Caplight tracks

Company Overview

Mabgeek Biotechnology is a biotechnology company that develops antibody-based therapeutics and provides related technical services.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Clinical Trials

Business Model

B2B

Customer Profile

Revenue Share, Government Contracts, Services & Consulting

AI Layer

Non-AI

Keywords

antibody drugsmonoclonal antibodiesmAbsclinical stage biotechbiologicsautoimmune disease therapyinflammatory disease therapyatopic dermatitis treatmentasthma treatmentanti-IL-4Rα antibodyeczema treatmentlong-acting antibodiesantibody discoverydrug developmenthybridoma platformIgA nephropathy treatment

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Mabgeek Biotechnology Comparables

Compare Mabgeek Biotechnology with similar companies based on industry and business-model similarity.

Mabgeek Biotechnology comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Connect Biopharma Holdings Limited
91%
KeyMed Biosciences
86%
Qyuns Therapeutics Co Ltd
86%

Mabgeek Biotechnology Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
IPOJul 14, 2025
VC RoundJul 1, 2025
Series BAug 12, 2024
Series AJul 1, 2017

Mabgeek Biotechnology Investors

Notable investors and investment history

Market signals

Structured signals derived from secondary market and firmographic data.

  • Aug 22, 2026

    Monthly visitors increased 52% MoM.

  • Jul 14, 2025

    Led by China International Capital Corporation

Mabgeek Biotechnology Filings

Explore SEC and related filing metadata, where available.

Mabgeek Biotechnology filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Mabgeek Biotechnology's valuation, stock price, and market status.

Is Mabgeek Biotechnology a public or private company?

Mabgeek Biotechnology is a private company.

What is the current stock price of Mabgeek Biotechnology?

Mabgeek Biotechnology is a private company with no public stock price. No recent secondary market data is available.

How much is Mabgeek Biotechnology worth (valuation)?

Mabgeek Biotechnology's valuation is estimated at $368.1M based on funding round data.

Can I buy Mabgeek Biotechnology stock?

Mabgeek Biotechnology shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Mabgeek Biotechnology's last funding round?

Mabgeek Biotechnology's most recent funding round was IPO on July 1, 2025.

Who are the main investors in Mabgeek Biotechnology?

Key investors in Mabgeek Biotechnology include China International Capital Corporation.

Will Mabgeek Biotechnology IPO soon?

No public IPO plans have been announced for Mabgeek Biotechnology.

How can I track Mabgeek Biotechnology secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Mabgeek Biotechnology's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersBeijing
Employee Range3
Year Founded2018
Last FundingJul 14, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?